International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
2025 · Journal of Clinical Oncology · 76 citations
https://doi.org/10.1200/jco-24-01893
M
Mattia D’Agostino
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
2.6K
Citations
28
h-index
47
i10-index
Mattia D’Agostino is an academic researcher from Azienda Ospedaliera Citta' della Salute e della Scienza di Torino. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 28, co-authored 115 publications.
ORCID: 0000-0002-1711-6996Papers by this author
worksGenomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024 · Blood Cancer Journal · 19 citations
https://doi.org/10.1038/s41408-024-01096-6
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023 · Experimental Hematology and Oncology · 9 citations
https://doi.org/10.1186/s40164-023-00434-x
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts
2025 · Annals of Hematology · 1 citations
https://doi.org/10.1007/s00277-025-06212-5
Supplementary Data 3 from Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27902390
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat